StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.69−0.23 (-0.82%)

Close on Nov 18, 2026Market cap $1.23BP/E –Yield –

Avalyn Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$28.94M–
Q1 FY2026Mar 31, 2026-$26.87M–
Q2 FY2025Jun 30, 2025-$20.19M–
Q1 FY2025Mar 31, 2025-$17.50M–

More Avalyn Pharma figures

See a number that looks wrong?